Rezumat
The study was carried out to document awareness, and acceptability of Human Papillomavirus virus (HPV) vaccines amongst staff of Obafemi Awolowo University lle-lfe. A cross-sectional survey of 400 members of staff who are parents of female children aged 10-19 years was conducted. Information on awareness on HPV infection and vaccine, attitude towards and parental acceptability of vaccine were collected using a structured self administered questionnaire. A total of 400 questionnaires were administered, 385(96.3%) were correctly filled and analysed. Only few (16.6 %) have heard of HPV infection, of which 31.7 % obtained information from the hospital. Majority (92%) believed that it protects against cervical cancer, 18.7% believed it causes HPV infection and 49.6% believed it will promote promiscuity. Majority ((84.4%) agreed that the vaccine should be included in the routine immunisation schedule. Most of the parents (81.0%) were willing to accept HPV vaccination. Parental
belief that the vaccine prevent cervical cancer (β=0.38, P<0.001) and parental agreement of its inclusion in routine immunisation (β= 0.12, P=0.002) were predictors of increased HPV acceptability. Increased parental HPV acceptability was associated with the belief that HPV vaccination was beneficial and protective to health. There is a need for it to be included in the pre-school immunisation programme.
Keywords: Parental acceptability, HPV vaccine, Awareness
Summary
The study was carried out to document awareness, and acceptability of Human Papillomavirus virus (HPV) vaccines amongst staff of Obafemi Awolowo University lle-lfe. A cross-sectional survey of 400 members of staff who are parents of female children aged 10-19 years was conducted. Information on awareness on HPV infection and vaccine, attitude towards and parental acceptability of vaccine were collected using a structured self administered questionnaire. A total of 400 questionnaires were administered, 385(96.3%) were correctly filled and analysed. Only few (16.6 %) have heard of HPV infection, of which 31.7 % obtained information from the hospital. Majority (92%) believed that it protects against cervical cancer, 18.7% believed it causes HPV infection and 49.6% believed it will promote promiscuity. Majority ((84.4%) agreed that the vaccine should be included in the routine immunisation schedule. Most of the parents (81.0%) were willing to accept HPV vaccination. Parental belief that the vaccine prevent cervical cancer (β=0.38, P<0.001) and parental agreement of its inclusion in routine immunisation (β= 0.12, P=0.002) were predictors of increased HPV acceptability. Increased parental HPV acceptability was associated with the belief that HPV vaccination was beneficial and protective to health. There is a need for it to be included in the pre-school immunisation programme.
Correspondence: Dr. O.A. Esimai, Department of Community Medicine, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria. E-mail: pejuesimai@yahoo.com
Referințe
Ho GY, Bierman R, Beardsley L, Chang CJ and Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998, 338(7):423-428.
Kotloff KL, Wasserman SS, Russ K, Shapiro S, Daniel R, Brown W, Frost A, Tabara SO and Shah K: Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis 1998, 25(5):243-250.
Franco E and Harper DM: Vaccination against human papillomavirus infection: A new paradigm in cervical cancer control. Vaccine 2005, 23(17–18):2388-2394.
Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE and Fortenberry JD: A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005, 191(2):182-192.
Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Desy M and Rohan TE: Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high risk area for cervical cancer. J Infect Dis 1999, 180(5):1415-1423.
Bosch, F. X., and Muñoz, N. The viral etiology of cervical cancer. Virus Research, 2002, 89: 183-190.
Giordano G, D’Adda T, Gnetti L, Froio E, Merisio C and Melpignano M: Detection of human papillomavirus in organs of upper genital tract in women with cervical cancer. Int J Gynecol Cancer 2006, 16(4):1601-1607
Schiffman M and Castle PE: Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003, 127(8):930-934.
Davis D, Dickman E D, Ferris D, and Dias, J. K. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. Journal of Lower Genital Tract Disease, 2004, 8: 188-194.
Koutsky L ., Ault, K A, Wheeler C M, Brown D R Barr, E, Alvarez, F B et al. Controlled trial of human papillomavirus type 16 vaccine.N Engl J Med.2002,347: 1645-1651.
Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R. et al. Prophylatic quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: A randomised double-blind placebo-controlled multicenter phase II efficacy trial. Lancet Oncology.2005, 6: 271-278.
Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis. 2005;191: 1796 –1807
Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis. 2002;186 :1396 –1402
Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis. 2001;183 :1554 –1564
Mays RM, Sturm LA and Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58 :1405 –1413
Freeman VA and Freed GL. Parental knowledge, attitudes, and demand regarding a vaccine to prevent varicella. Am J Prev Med. 1999;17 :153 –155
Poland GA and Jacobson RM. Understanding those who do not understand: a brief review of the anti-vaccine movement. Vaccine. 2001;19: 2440 –2445
Rosenthal SL, Kottenhahn RK, Biro FM and Succop PA. Hepatitis B vaccine acceptance among adolescents and their parents. J Adolesc Health. 1995;17 :248 –254
Zimet GD, Fortenberry JD, Fife KH, Tyring SK, Herne K and Douglas JM. Acceptability of genital herpes immunization. The role of health beliefs and health behaviors. Sex Transm Dis. 1997;24 :555 –560
John M, Yelena B, David D. B, Sasha C. K, Matthew B and Enrique S-Toriello. A Pilot Study: HPV Infection Knowledge and HPV Vaccine Acceptance among Women Residing in Ciudad Juárez, México. Californian Journal of Health Promotion 2006, (4); 3, 177-186.
Obiechina, N J A (NJ); Diwe, K (K) and Ikpeze, O C (OC); Knowledge, awareness and perception of sexually transmitted diseases (STDs) among Nigerian adolescent girls. J Obstet Gynaecol; 2002, 22: 302-305.
Constantine NA and Jerman P: Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 2007, 40(2):108-115.
Waller J, Marlow LA and Wardle J: Mothers’ attitudes towards preventing cervical cancer through humanpapillomavirus vaccination:a qualitative study. Cancer Epidemiol Biomarkers Prev 2006, 15(7):1257-1261.
Dempsey AF, Zimet GD, Davis RL and Koutsky L: Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006, 117(5):1486-1493.
Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez- Avila M and Munoz N: Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001, 32(3):243-247.
Zimet GD, Mays RM, Winston Y, Kee R, Dickes J and Su L: Acceptability of Human Papillomavirus Immunization. J of Women’s health & Gender-based medicine 2000, 9(1):47-50.
Zimet GD, Blythe MJ and Fortenberry JD: Vaccine characteristics and acceptability of HIV immunization among adolescents. Int J STD AIDS 2000, 11(3):143-149.
McPartland TS, Weaver BA, Lee SK and Koutsky LA. Men’s perceptions and knowledge of human papillomavirus (HPV) infection and cervical cancer. Journal of American College Health. 2005;53(3):225–230.
Holcomb B, Bailey JM, Crawford K and Ruffin MT. Adults’ knowledge and behaviors related to human papillomavirus infection. The Journal of the American Board of Family Practice. 2004;17(1):26–31.
Kahn JA, Rosenthal SL, Succop PA, Ho Gym and Burk RD. Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics. 2002;109(1):E5.
Dobson S, Deeks S and Money D: Déclaration sur le vaccin contre le virus du papillome humain. CCDR RMTC 2007, 33:32
Sauvageau C, Duval B, Gilca V, Lavoie F and Ouakki M. Human Papilloma Virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada .BMC Public Health 2007, 7:304
Zimet GD, Perkins SM, Sturn LM, Bair RM .Julia BE and Mays RM .Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Med 2005;37:179-186.